Annexon, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Annexon, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than almost all Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-1,233.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than almost all Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-64.1×Operating cash was negative last year, while some debt falls due within a year.
Lower than 77% of Healthcare companies in United States.
Cash Cushion Ratio
+29%Cash, after subtracting all debt, equals 29% of its market value (net cash).
Higher than 68% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Annexon, Inc. made a loss over the last year. Annexon, Inc. owes $0.24 for every $1 it owns. Annexon, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAnnexon, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.88The share price is 3.88 times Annexon, Inc.'s book value per share, higher than 64% of Healthcare companies in United States.
Market cap
$722 MThe total market value of all of Annexon, Inc.'s shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$186 MWhat Annexon, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.98Net worth divided by the number of shares. The share price of $3.81 is 3.9 times this, which is the P/B above.
Return on equity (ROE)
-105.3%Annexon, Inc. lost 105.3% of its shareholders' money over the last year, lower than 72% of Healthcare companies in United States.
Owes vs Owns
0.24×Annexon, Inc. owes $0.24 for every $1 it owns (low), lower than 67% of Healthcare companies in United States.
Dividend yield
NoneAnnexon, Inc. does not currently pay a dividend.
Profit growth
LossAnnexon, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashAnnexon, Inc. held $212 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Annexon, Inc.: $722 M ÷ $186 M (30 Jun 2026) = 3.9.
What is Annexon, Inc.'s return on equity?
Annexon, Inc. lost 105.3% of its shareholders' money over the last year, lower than 72% of Healthcare companies in United States.
How much does Annexon, Inc. owe compared with what it owns?
Annexon, Inc. owes $0.24 for every $1 it owns (low), lower than 67% of Healthcare companies in United States.
Does Annexon, Inc. pay a dividend?
No. Annexon, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.